Swiss Reinsurance Co. reported Thursday that the company earned 403 million Swiss francs ($373.4 million) in fourth-quarter net profit, according to Associated Press.
The quarterly profit was a stark increase from the 1.75 billion francs loss it suffered during the year-earlier period.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
The company said earnings per share were 1.18 francs, compared with a loss of 5.34 francs per share in the last three months of 2008. Full-year net profit for 2009 reached 506 million francs compared with a loss of 864 million the previous year.
Despite the rise, the quarterly results fell short of analysts' expectations.
The company’s operating income in its property and casualty business nearly doubled to 853 million francs. Swiss Re's combined ratio improved to 88.3 percent compared with 104.6 percent in the same period the previous year. A combined ratio below 100 percent indicates profitability in the insurance industry, according to AP.
Swiss Re's life and health insurance business saw a fall of operating income to 88 million francs from 224 million.
The asset management unit's return on investments dropped to 3.3 percent from 4.9 percent, partly due to writedowns of 248 million francs.
The company said it aims for a return on equity of 12 percent this year as it improves its investment portfolio and sells off undesirable assets.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.